Table 4.
Variables | Patients undergoing hepatectomy | Patients without hepatectomy | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariable | Multivariable | Univariable | Multivariable | |||||||||
HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | |
Gender | 0.684 | 0.386-1.213 | 0.194 | 0.356 | 0.969-1.896 | 0.085 | ||||||
Age | 0.858 | 0.537-1.369 | 0.520 | 1.462 | 1.117-1.913 | 0.006 | 1.225 | 0.933-1.609 | 0.144 | |||
T stage | 1.012 | 0.635-1.613 | 0.961 | 0.899 | 0.684-1.182 | 0.446 | ||||||
N stage | 0.586 | 0.365-0.942 | 0.027 | 0.641 | 0.389-1.057 | 0.082 | 1.071 | 0.816-1.408 | 0.620 | |||
Number of liver metastases | 0.847 | 0.528-1.359 | 0.491 | 1.016 | 0.774-1.335 | 0.906 | ||||||
Chemotherapy | 1.662 | 1.040-2.657 | 0.034 | 1.635 | 1.007-2.654 | 0.047 | 1.323 | 1.012-1.731 | 0.041 | 1.283 | 0.978-1.682 | 0.072 |
Ascites | 1.606 | 0.821-3.144 | 0.167 | 1.064 | 0.777-1.458 | 0.698 | ||||||
Peritoneal metastasis | 0.172 | 0.641-2.114 | 0.606 | 1.255 | 0.916-1.719 | 0.157 | ||||||
HR | 0.334 | 0.191-0.584 | <0.001 | 0.288 | 0.199-0.417 | <0.001 | ||||||
PLR | 1.423 | 0.890-2.275 | 0.140 | 1.644 | 1.235-2.188 | 0.001 | ||||||
PNI | 0.539 | 0.333-0.871 | 0.012 | 0.794 | 0.467-1.352 | 0.396 | 0.828 | 0.635-1.080 | 0.164 | |||
NLR | 1.209 | 0.756-1.933 | 0.428 | 1.221 | 0.933-1.599 | 0.146 | ||||||
HR+PLR | 2.288 | 1.566-3.344 | <0.001 | 1.933 | 1.246-2.998 | 0.003 | 2.215 | 1.757-2.793 | <0.001 | 2.143 | 1.698-2.705 | <0.001 |
HR: hazard ratio; 95% CI: 95% confidence interval.